首页> 外国专利> - Rapid massively parallel single-cell drug response measurements via live cell interferometry

- Rapid massively parallel single-cell drug response measurements via live cell interferometry

机译:-通过活细胞干涉测量法快速进行大规模平行单细胞药物反应测量

摘要

The central question in cancer therapy is the response pattern of individual cells in a tumor cell population to drugs designed to stop the growth of tumor cells. However, absolute growth of cells, changes in physical mass, whether cancerous or physiological, are difficult to measure directly by the prior art. Embodiments of the present invention provide live cell interferometry (LCI) for rapid, real-time quantification of cell mass in cells exposed to a changing environment. Overall, LCI provides conceptual advances in evaluating cell populations to identify, monitor, and measure single cell responses such as therapeutic drugs.
机译:癌症治疗中的中心问题是肿瘤细胞群中单个细胞对旨在阻止肿瘤细胞生长的药物的反应方式。然而,现有技术难以直接测量细胞的绝对生长,物理量的改变,无论是癌变的还是生理的。本发明的实施例提供了活细胞干涉测量法(LCI),用于对暴露于变化的环境的细胞中的细胞质量进行快速,实时的定量。总体而言,LCI在评估细胞群以识别,监测和测量单细胞反应(例如治疗药物)方面提供了概念上的进步。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号